Squarepoint
TWST icon

Squarepoint’s Twist Bioscience TWST Stock Holding History

Squarepoint’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.11M Sell
39,981
-113,545
-74% -$7.39M ﹤0.01% 1731
2026
Q1 		$7.3M Buy
153,526
+117,809
+330% +$5.28M 0.01% 1257
2025
Q4 		$1.13M Sell
35,717
-40,080
-53% -$1.25M ﹤0.01% 2497
2025
Q3 		$2.13M Buy
75,797
+4,089
+6% +$124K ﹤0.01% 2044
2025
Q2 		$2.64M Buy
71,708
+47,221
+193% +$1.63M ﹤0.01% 1893
2025
Q1 		$961K Sell
24,487
-3,279
-12% -$148K ﹤0.01% 2704
2024
Q4 		$1.29M Sell
27,766
-245,678
-90% -$11.1M ﹤0.01% 2822
2024
Q3 		$12.4M Buy
273,444
+262,953
+2,506% +$12.5M 0.02% 843
2024
Q2 		$517K Sell
10,491
-147,925
-93% -$6.03M ﹤0.01% 3052
2024
Q1 		$5.44M Buy
158,416
+80,451
+103% +$2.9M 0.01% 1379
2023
Q4 		$2.87M Buy
77,965
+47,296
+154% +$1.09M 0.01% 1760
2023
Q3 		$621K Buy
+30,669
New +$674K ﹤0.01% 2631
2023
Q2 		– Sell
-134,772
Closed -$2.03M – 4030
2023
Q1 		$2.03M Buy
+134,772
New +$2.98M 0.01% 1407
2022
Q4 		– Sell
-36,488
Closed -$1.29M – 3615
2022
Q3 		$1.29M Sell
36,488
-21,340
-37% -$906K 0.01% 1591
2022
Q2 		$2.02M Buy
57,828
+10,827
+23% +$384K 0.01% 1184
2022
Q1 		$2.32M Buy
47,001
+38,664
+464% +$2.14M 0.01% 1071
2021
Q4 		$645K Buy
8,337
+5,427
+186% +$557K ﹤0.01% 1982
2021
Q3 		$311K Buy
+2,910
New +$333K ﹤0.01% 2243
2021
Q1 		– Sell
-1,889
Closed -$267K – 3635
2020
Q4 		$267K Buy
+1,889
New +$210K ﹤0.01% 2300
2020
Q3 		– Sell
-7,998
Closed -$362K – 2849
2020
Q2 		$362K Sell
7,998
-6,434
-45% -$231K 0.01% 1485
2020
Q1 		$441K Sell
14,432
-82,595
-85% -$2.22M 0.01% 1108
2019
Q4 		$2.04M Sell
97,027
-9,387
-9% -$220K 0.01% 894
2019
Q3 		$2.54M Buy
106,414
+31,274
+42% +$909K 0.02% 751
2019
Q2 		$2.18M Buy
+75,140
New +$1.99M 0.02% 799

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Squarepoint's TWST Position: Q2 2026 in Review

Squarepoint reduced its Twist Bioscience (TWST) stake by 74% in Q2 2026, selling an estimated $7.39M and leaving 39,981 shares worth $4.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1731.

Squarepoint first reported a position in TWST in Q2 2019 and has held it in 24 quarters since. The position peaked at $12.4M in Q3 2024. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Squarepoint held 39,981 shares of Twist Bioscience worth $4.11M as of Q2 2026.
  • Squarepoint sold 113,545 Twist Bioscience shares in Q2 2026, an estimated $7.39M.
  • Twist Bioscience made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #1731 holding.
  • Squarepoint first reported a position in Twist Bioscience in Q2 2019 and has held it in 24 quarters since.
  • Squarepoint's Twist Bioscience position peaked at $12.4M in Q3 2024.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.